Determinants of Anti-Fibrotic Response to Mineralocorticoid Receptor Antagonist Therapy: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (Ephesus) and Early Eplerenone Treatment in Patients with Acute St-Elevation Myocardial Infarction Without Heart Failure (Reminder) Trials
AuthID
P-00Q-SAM
P-00Q-SAM